/manager/Index ${session.getAttribute("locale")} 5 Spinal multiparametric MRI and DEXA changes over time in men with prostate cancer treated with androgen deprivation therapy: a potential imaging biomarker of treatment toxicity /manager/Repository/uon:33054 5 % BMD loss after 1 year had triple the percentage increase in MRS FF at 6 months (61.1 % vs. 20.9 %, p = 0.19). Conclusions: Changes are observed on L-spine MRI after 6 months of ADT. Further investigation is warranted of MRS change as a potential predictive biomarker for later BMD loss.]]> Wed 04 Sep 2019 09:54:20 AEST ]]> Phase 2 multicenter study of gantry-based stereotactic radiotherapy boost for intermediate and high risk prostate cancer (PROMETHEUS) /manager/Repository/uon:34741 Tue 03 Sep 2019 18:02:19 AEST ]]> Validity of the common cold questionnaire (CCQ) in asthma exacerbations /manager/Repository/uon:4455 Sat 24 Mar 2018 10:12:16 AEDT ]]>